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ABSTRACT 
The short- and long-term effects of' !i-bromoclcoxyuricline !BrdU) on 13-16 mouse melanoma 
cells were studied by electron microscopy and histochemistry. 
The short term treatment with BrdU cam;cd reduced tyrosinru-e activity and !ootriking-
alteratiOn!' ot melnnosomes. Prnlonged exposure to increasingly larger doses of Brdllled to a 
complete los' of melanosomes and t~ rosinase act i\it). Both !oohort and long-term treatment 
led to depigmentation. The short-term changes were reversible. the long-term change" were 
not. Amelanotir melanomas produced b) injecting BrdU-tolerant cells into mice were 
ultrastructurally and histochemically similar to those produced by selection without BrdU 
treatment. an indication that the changes induced bv BrdU were not specific. 
Se\·eral author.; have reported that .l-bromo-
deoxyuridine (BrdUl, a thymidine analog. modi-
lies ditlerentiation and cam.es structural alteration 
in many cell linE's [1 8]. Pigmented melanoma 
cells grown in medium t•ontaining RrdU lost pig-
ment and became larger and more contact inhib-
ited: injected into mice. they produced amelanot ic 
tumors [9]. These change!< were not re\erstble even 
after the cells had been rerurned to and grown in 
analog-free medium for more than a year [10 1. 
Silagi and co-workers reported similar morphologic 
changes. loss of pigmentation. and loss of tumori-
genicity in these t•ells aftt·r short-term treatment 
with low doses of Brdl These changes. howe\'er. 
were re,·ersible when the cell:. were returned to 
growth medium without BrdC [8]. 
In this paper. we report our electron microscopic 
and h istochem ica I ohserva Lions on the short- and 
long-lPrm effects of high and low doses of Brdl' on 
pigmented melanoma cell.- in culture and on the 
ultrastructural t·haracteristics of amelanotic tu-
mor~; produced by BrdU-tolerant cells. For com-
panson. we also include a nonpigmented tumor 
produced by the selection of nonpigmented mela-
noma cells through in vitro and in vivo passages. 
Our data indicate that BrdU interferes with the 
normal development of melanosomes and thus 
leads to the loss 1f pigmentation. 
MATERIALS A:\0 METIIOOS 
Cell Culture, BrdU Treatm rnt, and Tumor InductiOn 
The cell line 440B u~ed in this study was eblablished in 
\tonuscript receiv!'d Augt.l't 27 197:1, in rcv b.ed form 
Dl'<'emher 27. 197 . acrl•pted fi1r publi~·ation .Janual"\ :?. 
1911 
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the Animal Resources Hranch, Division Clf Research 
RC!\ourret,, AM OA445 of the "'ationallnstitute of Arthri · 
lls, Metabolism and Di~eestive Diseases. and Ca 08499 
of the National Cancer Institute. 
pure culture from a B 16 murine melanuma. The hi:.tory 
of tht~ cell line ha>- !wen summarized elsewhere [9, 10 I 
For the stud~ of the early effects of BrdL. cells were 
gwwn in Falcon plaMIC culture na .. k~ (30 mil for 2 a 
days : when they appcnrcd a~ monolayer aggre~ates. they 
were treated with Brdl! tC'albiocbem. C'u I. a~ follow!. 
Short-term treatmrnt Brdl: 15 -:Jil pKfml medium for 
17 hr ur BrdU 3 IliUm I lor 3 and 6 day~ . 
LonR-term treatment A BrdU-tnlcrant melanoma celt 
line wa" obtained b) expo~inJ:" cells to increasing do>es 
(:l .lfi l'idml of Brdl!) fur more than a year [91. ome of 
the~e tolerant cells were transferred back into analog-free 
medium for 5' ., months at the time of examination. 
Tumol':l were pmduced in C57HU6 mice by a si n~le 
Inject ton of 1 ~ 10• celll-. Both the cells that had been 
maintnmed continuoul'h in Brdl' and those that had 
been 1 ransferred tn the analog-free medium produced 
nonpigmented tumnn. [10 ]. Another nonpigmented t u 
rTHlr, which had never been expo~ccl t<l Brdl' [11), wa~ 
also included in this study . 
E/pctrcm Microsrop\' and Hi.~tochemr.'tr\ 
Cultured cell~< wt>rP fixed in situ w llh 2.7't. glutaralde-
hyde m Millonif!'l- phosphate buffer l'or 60 min. wa,hed 
twice with buffer for 1;; min. and pn~tfixed with I"'• 
osmium tetroxide lor :~n min. The material!\ were dehy 
drated wiih graded ethnnol and embedded in Epon A12 
Selected areas were marked under light microscope and 
thin sect ions were made from them 112) 
Tumors were d.-set"ted, cut into 1 mm• p1eces. and 
fixed immediateh with cold I"' osmium tetroxide m 0 I 
M cat·od~·late buffer for~ hr: they were then dehydrated 
with ~:raded ethanol and embedded in Ep<1n 812 
Fnr dopa histochemi~tl'), cultured t'CIIb were fixed with 
2.7'';, glutaraldehyde in 0.1 M phosphatl' buffer, pH 7.-t, 
for lfi min, washed twice with the same buffer for 15 min , 
and incubated in 0. I" L·:l.4-dihydrnxyphenylala.nine 
(OOPA. Sigma Chemtral C'o.J solution in 0 1 t\1 pho,;-
phate buffer, pH 7 .I, for 5 hr. at 37 .. C Tumors were f1xed 
with 2.7r~. glutaruldehyde 1n 0.1 M ph!l~phnte buffer. pH 
7.1, for I hr, wa:.hed wnh the :.arne buffer, incubated in 
tl.t "; dopa solution for 5 hr at 37°<', und o!.!micated. 
For al·id phm.phatase activity, the tumors were fixed in 
1 .n'~ glutaraldehvdc in 0 1 M cacodylate buffer for 1 hr, 
rmsed in the same buffer. and rapidly frm.en. Forty p 
sertttmli were cut in a l'ryo~tat. incubated in Gomori'l' Thi~ work wa" presented at the Annual Me~: I ing of the 
Soctety for lD\'CStagative Dermatolo~·. '\ew York Cit}. 
June 22, 1913. Regional Primate RC!\earch Ce11ter. Heaverton. Oregon 
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F1c. 1: Pigmented melanoma cells exposed to Brdl' l5 10 ,glml for 17 hr Many melanosomeo; conglomerated to form melanosome complexes (arrowsl. and myelin-like figure.- appeared in melanosomes (insert) ( 60,000: insert >< 
168,000) 
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medium [Ia) at a;•r. and osmicatcd 
Colloidal ~told sulution (Mathcl'on Coleman and Bell 
Co .. solution for Lnnl(e~· tPst) was u~ed to leRt whether 
any organelles in the melanomas had phallOCytic activity. 
A total of about 0.6 ml of injectuble colloidal gold soluuon 
{ 10 l'g ' ml t•nncenlrnllonl wa~ nfilt rated into the tumor 
ma~!> which was removed 1 and 2 hr after injection nnd 
proce~sed for elcl'tron micrnsc(lpy 
Thin sect ions were cut with a Porter-Blum ~1T 11 
ultratome. stained with uron~·l acetate and lead citrate, 
and examined in a Philips 200 mtcrost·ope. 
R~Ll.TS 
Short-Term Expo.~ure to BrdU 
BrdU 15-30 llg/ml for 17 hr. After such exposure, 
pigmented melanoma cells still contained many 
melanosomes of different stages around the nuclei 
or distributed peripherally. The morpholog) of 
melanosomes in the BrdU-treated cells was strik-
ingly different from that in control cells (Fig. 1): 
(1) Melanosomes in different stages aggregated to 
form melano:some complexes: (2) these melann-
some complexes varied greatly in size and shape; 
(3) many myelin like structures appeared as con-
centric )aye!'!> of electron-opaque membranous 
components with a periodicity of approximately :10 
A. This periodicity was much shorter than that of 
the membranes of normal melanosomes. which is 
about 80 A. 
Other cytoplasmic organelles. i.e., microtubules, 
microtilament:s, mttochondria. Golgi complexe~. 
and endoplasmic reticulum. showed no apparent 
alteration at this time. 
BrdU 3 llg/ml for 3 and 6 dan. These melanoma 
cells showed a reduction of melanosomes. Other 
cytoplasmit· urganelles appeared unchanged and 
resemhled those in the untreated control cells. 
Dopa reaction products were present in the Golgi 
cisternae, Golgi-associated vesicle', and melano-
somes. Some reaction products were also present in 
the peripheral margin of \·acuoles (Fig. 2). 
Except for a few fully melanized melanosomes 
(Stage IV) , cells exposed to BrdU for 6 days had no 
normal-looking melanosomes and were not dopa-
reactive; instead their cytoplasm contained many 
dense bodies (Fig. :l). These were round or ovoid, 
had a homogeneous electron-dense matrix bound 
by a unit membrane. and contained lamellated 
membranous structures which could be morpho-
logically classified as lysosomes. None of these 
dense bodies showed dopa reaction products. ln 
addition. many vesicles were seen in the vicinity of 
the Golgi complexes (Fig. :ll. 
Long-Term Effect 
BrclU-tolerant cells continuously exposed to ana-
log showed the following changes: (1) Complete 
absence of melanosomes; (2) lack of tyrosinase 
activity; (:1) appearance of dense hodies (Fig. 4) 
'0 
Ftc 2: Melanoma cell~ expo~ed to BrdU 31'g/ml for 3 day~. Dopa react ton products '~ere found in Golgi cisternae, 
Golgi vesicle~. and vacuoles (arrows) (insen) ( · 7.000; insert 60.000) 
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F1c. 3: \i1elanoma celb expo,ed to BrdU 3 pg/ml for 6 days lacked dopa reaction product,; and melanosomes except for a few fully melanized on~ (arrow I. and manv lamella ted dense bodie, appeared Cino;ert) . I x 9.000: in~ert x i2.0001 
FIG. 4: BrdU-tolerant cells continuously exposed to analog. ( v 60,0001 
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which were mostly lamellated and electron-opaque 
and could be classified as residual bodies. 
BrdU-tolerant cells grown in analog-free 
medium. There was no detectable difference be-
tween BrdU-tolerant cells [,'TOwn continuously in 
the analog medium and those t ran sf erred back to 
analog-free medium. All BrdU-tolerant cells 
lacked melanosomes and tyrosinase activity. Both 
cells had lamellated lysosomal bodies with high 
electron opacity. 
Nonpigmented Melanoma.~ 
Amelanotic tumor produced by BrdU-tolerant 
cells. BrdU-tolerant celb injected into C57BL mice 
produced amelanotic tumors which remained non-
pigmented after numerous passages for 2 years. As 
in Brd U-tolerant cells in culture, the main change. 
other than a complete loss of melanosomes and 
tyrosinase activity, was the appearance of many 
dense bodies in the cytoplasm. These bodies were 
mostly round but sometimes elongated to form 
tubular structures. They varied from 25 to :330 nm 
in diameter and contained fine granular matrices 
fringed by an elect ron-lucid rim and enclosed by a 
unit membrane (Fig. 5). Acid phosphatase acti' ity 
was sel dom detected. Exogenous colloidal gold was 
not incorporated into these dense bodies. 
In addition, virus-like particles existed in the 
dilated, rough-surfaced endoplasmic reticulum of 
some cells as well as in the intercellular spa,·es. We 
found doughnut-shaped type-A particles mostly in 
the cytoplasm and mature type-C particles (14 ] 
mainly extracellular (Figs. 6. 7). Virus-like parti-
cles in the endoplasmic reticulum sometimes 
showed bamboo-like structure,; sim ilar to those 
described by Rose et al [15 ]. T he cytoplasm had 
many free ribosomes, mitochondria, microfila-
ments, and a few annulate lamellae. 
Amelanotic tumor neuer exposed to BrdU. The 
ultrastructure of all amelanotic melanomas. 
Ftc. 5: Den~e bodies enclcsed by a unit membrane. ( 
44,000) 
Ftc. 6: Virus-like panicles sometimes showed a bam· 
boo-like stmcture (arrow). ( ~ 70,400) 
Ftc. 7: Budding \' irus-like particle. ( • 120.000) 
whether produced by BrdU treatment or not, were 
s imilar in many respects (Fi,;. 8A). All contained 
many dense bodies (Figs. 88, C) and virus-like 
particles and lacked tyrosinase acti\'ity. Occasion-
ally, however, the tumors that had never been 
exposed to the analog had rare bodies similar to 
stage II melanosomes (Fig. 8Dl. 
DISCUSSION 
The immediate changes induced by BrdU in 
pigmented melanoma cells were (1) loss of melano-
somes, (2) loss of tyrosinase activity, (3) formation 
of melanosome complexes, and (4) myelin-like 
structures. These changes were more str iking at 
high doses ( l5-30 /J.g/ml) , more gradual at low 
doses (3 /J.g/ml), and appeared predom inantly on 
the less mature melanosomes. Stage IV melano-
somes seemed to be unaffected. 
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Ftc. 8: (A) Amelnnotic tumor never expo~ed to BrdL These cells lacked tyrosinase acttnly and most 
melnnosomes. (. 7,000). (8 and CJ Different type" of den"e bodies found tn an amelnnoltl' tumor I 44.000). (0) Melanosome-ltke structure found in an amelanotic tumor I 168.0001 
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Wrathall et al, who recently studied the proce~s 
of pigment suppression by Brd U m melanoma cells 
[16], showed that tyrosinase activity gradually 
declined until it approa(·hed zero by 7 days and 
that most of the melanosomes, except a few fully 
melanized ones, we' re lost by th is time. Our short -
term results generally af{ree with theirs . The reduc-
tion of tyrosinase acth.it) correlated with the 
disappearance of \nelanosomes. The formation of 
melanosome complexes and lysosome-like organ-
elles in cells exposed to BrdU suggests increased 
degradation or degenerat iOn of melanosomes. Sim i-
larly. those myelin-like structures observed in 
cells exposed to high concentrations of Brd U 
( 15-30 J.Cg/ml) appear to indicate a degenerat ive 
process. These structures , however. were not 
unique to Brd U-t rcated cells but were also found in 
untreated cells, especially in old culturest. These 
changes. therefore, a re nonspec·ific and can occur 
with or without BrdU treatment However, wi thout 
doubt. BrdU induced the changes that led to the 
loss of pigmentation in treated cells. Prolonged 
exposure to BrdlJ led to the complete loss of 
melanosomes and tyrosinase activit). Density gra-
dient centrifugation studies indicate that Brdl' is 
incorporated into nuclear DNA [17]. but how it 
acts on the developing melanosome~ is not under-
stood. 
BrdU-tolerant cells contained dense bodies 
which were sometimes associated with lamellated 
structures. These bodie>. appeared to be the pre~·a· 
lent organelles in all nonpigmented cells-BrdU-
tolerant cells in and out of ana log-containing 
medium, nonpigmented tumors never exposed l<l 
BrdU, as well as cultured cells exposed to BrdU 
over a period of 6 7 days The lamellated dense 
bodies found in BrdU-treated culture cell~> mav be 
secondary lysosomes or residual bodies deri\'ed 
from remnants of degraded melanosomes. How-
ever, thei r failure to incorpora te exogenous colloi-
dal gold and thei r lack of acid phosphatase activity 
argue against this possibility. 
Morphologica lly, the membrane-bound den:-;e 
bodies in nonpigmented tumors resemble secretory 
granules ra ther than lysosomes . Whether the) are 
malformed melanosomes that have lost or had 
never acquired a well -organized ma trix and perio-
dicity or whether the) are l}·sosomes in a broad 
sense is not yet known. 
Virus-like particles are not uncommon in mouse 
tumors although their oncogenic significance is 
unclear. Silagi et al reported increased number::. of 
viruses in melanoma cell s a lter BrdU treatment 
and found some correlat ion between their number 
and the degree of their tumorigenicity [18 ). We 
have, however, no definite evidence to show any 
correla tion between viruses and BrdU treatment. 
Almost all ultrastructural a\-. well as histochemi-
cal changes mduc:ed by Brd U treatment were 
:j: Hu F: Unpubli~hed data 
found 111 untreated amelanotic melanomas. These 
changes. there fore, a re not specific for Brd U. They 
may represent merely the changes undergone by 
developi ng melano~omes in response to abnormal 
conditions which generally lead to a failure of 
normal melanosome biosynthesis. The immediate 
short -term reversible effects may be mainly due to 
increased melano:,ome degradation or degenera-
tion; most probably the long-term irre\'ersible 
effects result from the selection of a rare amela-
notic variant or the induction of mutation(sl hy 
BrdU. 
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